D-Index & Metrics Best Publications

Manfred Dietel

Charité - University Medicine Berlin
Germany

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 87 Citations 23,292 403 World Ranking 8898 National Ranking 460

Overview

What is he best known for?

The fields of study Manfred Dietel is best known for:

Cancer
Gene
Chemotherapy

Manfred Dietel combines Cancer and Breast cancer in his studies. Breast cancer and Cancer research are two areas of study in which he engages in interdisciplinary research. His study deals with a combination of Cancer research and Chemotherapy. Manfred Dietel merges Chemotherapy with Cancer in his study. Internal medicine is frequently linked to Immunohistochemistry in his study. He integrates many fields in his works, including Immunohistochemistry and Tissue microarray. Manfred Dietel regularly links together related areas like Internal medicine in his Tissue microarray studies. His study on Pathology is mostly dedicated to connecting different topics, such as Carcinoma. His study brings together the fields of Pathology and Carcinoma.

His most cited work include:

Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer (1316 citations)
Mucosal flora in inflammatory bowel disease (1233 citations)
Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers (777 citations)

What are the main themes of his work throughout his whole career to date

Manfred Dietel incorporates Cancer and Breast cancer in his studies. Manfred Dietel integrates Breast cancer and Cancer in his research. He combines topics linked to Ovarian cancer with his work on Internal medicine. His study in Internal medicine extends to Ovarian cancer with its themes. Manfred Dietel combines Pathology and Immunohistochemistry in his research. His multidisciplinary approach integrates Immunohistochemistry and Pathology in his work. Manfred Dietel brings together Cancer research and Oncology to produce work in his papers. Manfred Dietel brings together Oncology and Cancer research to produce work in his papers. Manfred Dietel undertakes interdisciplinary study in the fields of Genetics and Molecular biology through his research.

Manfred Dietel most often published in these fields:

Cancer (71.24%)
Internal medicine (63.73%)
Pathology (60.78%)

What were the highlights of his more recent work (between 2015-2021)?

Internal medicine (70.45%)
Cancer (65.91%)
Pathology (56.82%)

In recent works Manfred Dietel was focusing on the following fields of study:

His study brings together the fields of Concordance and Internal medicine. His Concordance study frequently draws connections between adjacent fields such as Internal medicine. In his research, he undertakes multidisciplinary study on Cancer and Colorectal cancer. Manfred Dietel combines topics linked to Serous fluid with his work on Pathology. His work on Pathology expands to the thematically related Serous fluid. His work blends Oncology and Cancer research studies together. He performs integrative Cancer research and Oncology research in his work. He merges Gene with Immunohistochemistry in his research. His work often combines Immunohistochemistry and Gene studies.

Between 2015 and 2021, his most popular works were:

A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal (614 citations)
Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas (317 citations)
Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non–Small-Cell Lung Cancer (312 citations)

In his most recent research, the most cited works focused on:

Cancer
Lung cancer
Gene

The study of Serous carcinoma and Ovarian carcinoma are components of his Ovarian cancer research. Much of his study explores Ovarian carcinoma relationship to Ovarian cancer. His Internal medicine study frequently draws connections to adjacent fields such as Serous carcinoma. In his research, Manfred Dietel performs multidisciplinary study on Cancer and Medical physics. In his papers, Manfred Dietel integrates diverse fields, such as Medical physics and Cancer. His Malignant pleural effusion research extends to the thematically linked field of Oncology. Malignant pleural effusion and Anaplastic lymphoma kinase are frequently intertwined in his study. His Anaplastic lymphoma kinase study frequently draws connections to other fields, such as Oncology. His Clinical trial research extends to the thematically linked field of Pathology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers

Carsten Denkert;Gunter von Minckwitz;Jan C. Brase;Bruno V. Sinn.
Journal of Clinical Oncology (2015)

1045 Citations

A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

Guido Rindi;David S. Klimstra;Behnoush Abedi-Ardekani;Sylvia L. Asa.
Modern Pathology (2018)

615 Citations

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

Josef Rüschoff;Manfred Dietel;Gustavo B Baretton;Susanne Arbogast.
Virchows Archiv (2010)

554 Citations

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

W Weichert;A Röske;V Gekeler;T Beckers.
British Journal of Cancer (2008)

521 Citations

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.

Douglas D. Ross;Weidong Yang;Lynne V. Abruzzo;William S. Dalton.
Journal of the National Cancer Institute (1999)

489 Citations

Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors.

Carsten Denkert;Jan Budczies;Tobias Kind;Wilko Weichert.
Cancer Research (2006)

436 Citations

Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis

Wilko Weichert;Annika Röske;Volker Gekeler;Thomas Beckers.
Lancet Oncology (2008)

391 Citations

Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas.

Olaf Kaufmann;Ellen Fietze;Jörg Mengs;Manfred Dietel.
American Journal of Clinical Pathology (2001)

380 Citations

Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites.

O Kaufmann;M Dietel.
Histopathology (2000)

356 Citations

Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover.

Carsten Denkert;Jan Budczies;Wilko Weichert;Gert Wohlgemuth.
Molecular Cancer (2008)

355 Citations

If you think any of the details on this page are incorrect, let us know.